These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25083710)

  • 1. Clearing the fog of anticancer patents from 1993-2013: through an in-depth technology landscape & target analysis from pioneer research institutes and universities worldwide.
    Dara A; Sangamwar AT
    PLoS One; 2014; 9(8):e103847. PubMed ID: 25083710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technology whitespaces India should focus: a comparative anti-cancer patent rational analysis of Indian and international public funded universities.
    Dara A; Sangamwar AT
    Recent Pat Anticancer Drug Discov; 2015; 10(2):163-9. PubMed ID: 25751276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer patent landscape and technology assessment of Indian public-funded research institutes and organizations.
    Dara A; Sangamwar AT
    Expert Opin Ther Pat; 2014 Aug; 24(8):893-912. PubMed ID: 24898985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
    Musyuni P; Aggarwal G; Nagpal M; Goyal RK
    Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis between academic and patent publications based on Fenton Technologies among China, Brazil, and the rest of the world.
    de Luna AJ; Santos DA
    Environ Sci Pollut Res Int; 2017 Mar; 24(7):6106-6113. PubMed ID: 27094267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of Digital Health and Exploration of Patented Technologies (2017-2021): Bibliometric Analysis.
    Gu W; Wang J; Zhang Y; Liang S; Ai Z; Li J
    Interact J Med Res; 2024 Jul; 13():e48259. PubMed ID: 38991212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
    Siri JGS; Fernando CAN; De Silva SNT
    Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capturing 'R&D excellence': indicators, international statistics, and innovative universities.
    Tijssen RJW; Winnink JJ
    Scientometrics; 2018; 114(2):687-699. PubMed ID: 29449752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Liposomes in Cancer Therapy: An Assessment of the Advancement of Technology Through Patent Documents.
    Nunes DDG; Leal IL; Oliveira FO; da Silva TLR; de Senna V; Machado BSS
    Recent Pat Nanotechnol; 2021; 15(4):367-376. PubMed ID: 33357205
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Machuca-Martinez F; Amado RC; Gutierrez O
    Data Brief; 2020 Jun; 30():105551. PubMed ID: 32337328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty five years of the National Academy of Medical Sciences of Ukraine - progress and priorities for future of radiation medicine and biology.
    Bazyka D
    Probl Radiac Med Radiobiol; 2017 Dec; 22():10-14. PubMed ID: 29286493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying the trends in wound-healing patents for successful investment strategies.
    Gwak JH; Sohn SY
    PLoS One; 2017; 12(3):e0174203. PubMed ID: 28306732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of cutting-edge therapies for hepatocellular carcinoma (HCC): Perspectives from patents.
    Gao Y; Lyu L; Feng Y; Li F; Hu Y
    Int J Med Sci; 2021; 18(14):3066-3081. PubMed ID: 34400877
    [No Abstract]   [Full Text] [Related]  

  • 16. Patenting of university and non-university public research organisations in Germany: evidence from patent applications for medical research results.
    Tinnemann P; Ozbay J; Saint VA; Willich SN
    PLoS One; 2010 Nov; 5(11):e14059. PubMed ID: 21124982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal drug patenting in India: IP potential.
    Sahoo N; Manchikanti P; Dey SH
    J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of R&D expenditures on research publications, patents and high-tech exports among European countries.
    Meo SA; Usmani AM
    Eur Rev Med Pharmacol Sci; 2014; 18(1):1-9. PubMed ID: 24452936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technological Innovations in Disease Management: Text Mining US Patent Data From 1995 to 2017.
    Huang M; Zolnoori M; Balls-Berry JE; Brockman TA; Patten CA; Yao L
    J Med Internet Res; 2019 Apr; 21(4):e13316. PubMed ID: 31038462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact factor-based quality assessment of biomedical research institutes in Iran: effect of impact factor normalization by subject.
    Rezaei-Ghaleh N; Azizi F
    Arch Iran Med; 2007 Apr; 10(2):182-9. PubMed ID: 17367221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.